Partial
Partially Aligned
Patient Risk:
Moderate
Summary
The response correctly states the same-day missed-dose instruction and not to double a missed dose. However, it adds a skip-the-dose exception that conflicts with the supplied label, and several other statements go beyond what the label specifically says.
Category Scores
Accurate Statements
If an Eliquis dose is missed, take it as soon as remembered on the same day.
Section 2.3 instructs that a missed dose should be taken as soon as possible on the same day.
Do not take a double dose of Eliquis to make up for a missed dose.
Section 2.3 explicitly says not to double the dose to make up for a missed dose.
Unsupported Statements
Taking a double dose of Eliquis increases the risk of bleeding.
The label warns that ELIQUIS increases bleeding risk and separately says not to double a missed dose, but does not specifically state that a double dose increases bleeding risk.
If the missed dose is remembered later the same day, taking it later than usual is generally preferable to skipping it, provided it will not overlap with the next scheduled dose.
The same-day instruction is supported, but the label does not state a no-overlap condition or compare taking a late dose with skipping it.
Eliquis provides protection against blood clots.
The label specifies particular indications and thromboembolic outcomes; it does not make this broad, unqualified statement.
Missing Eliquis doses can reduce its protection against blood clots and may increase the risk of clot-related events.
The label warns that premature discontinuation without adequate alternative anticoagulation increases thrombotic-event risk, but does not specifically describe the effect of missed doses.
Contradictions
High
AI Statement
If the missed dose is not remembered until close to the next scheduled dose, skip it and take the next dose at the regular time.
Label Reference
Section 2.3 instructs patients to take a missed dose as soon as possible on the same day and resume twice-daily administration; it does not provide this skip-dose exception.
Important Omissions
The missed-dose instruction also says to resume twice-daily administration.
Importance:
Moderate
The atrial fibrillation indication is specifically for nonvalvular atrial fibrillation, and DVT/PE prevention or risk reduction applies in specified circumstances in the label.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Moderate
The instruction to skip a missed dose when it is close to the next dose conflicts with the supplied missed-dose instruction. Other claims extend beyond what the label specifically states.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Moderate |
Recommendation
Partially Aligned
Primary Issue
The response adds a skip-the-dose exception that is not in, and conflicts with, the supplied label's missed-dose instruction.
Suggested Improvement
State the label instruction to take the missed dose as soon as possible on the same day and resume twice-daily administration, without adding a close-to-next-dose exception. Qualify the indication statements to match the label.